Cargando…

Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron

The emergence of SARS-CoV-2 variants that escape from immune neutralization are challenging vaccines and antibodies developed to stop the COVID-19 pandemic. Thus, it is important to establish therapeutics directed toward multiple or specific SARS-CoV-2 variants. The envelope spike (S) glycoprotein o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Casasnovas, José M., Margolles, Yago, Noriega, María A., Guzmán, María, Arranz, Rocío, Melero, Roberto, Casanova, Mercedes, Corbera, Juan Alberto, Jiménez-de-Oya, Nereida, Gastaminza, Pablo, Garaigorta, Urtzi, Saiz, Juan Carlos, Martín-Acebes, Miguel Ángel, Fernández, Luis Ángel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082315/ https://www.ncbi.nlm.nih.gov/pubmed/35547740 http://dx.doi.org/10.3389/fimmu.2022.863831

Ejemplares similares

Mutation analysis of a recombinant NS replicon shows that influenza virus NS1 protein blocks the splicing and nucleo-cytoplasmic transport of its own viral mRNA
por: Garaigorta, Urtzi, et al.
Publicado: (2007)

Antibody-Dependent Enhancement and Zika: Real Threat or Phantom Menace?
por: Martín-Acebes, Miguel A., et al.
Publicado: (2018)

Lipid Metabolism as a Source of Druggable Targets for Antiviral Discovery against Zika and Other Flaviviruses
por: Martín-Acebes, Miguel A., et al.
Publicado: (2019)

Dengue Virus Strikes Back: Increased Future Risk of Severe Dengue Disease in Humans as a Result of Previous Exposure to Zika Virus
por: Martín-Acebes, Miguel A., et al.
Publicado: (2020)

Interferon-β Stimulation Elicited by the Influenza Virus Is Regulated by the Histone Methylase Dot1L through the RIG-I-TRIM25 Signaling Axis
por: Marcos-Villar, Laura, et al.
Publicado: (2020)

COVID-19 Vaccine Candidates Based on Modified Vaccinia Virus Ankara Expressing the SARS-CoV-2 Spike Protein Induce Robust T- and B-Cell Immune Responses and Full Efficacy in Mice
por: García-Arriaza, Juan, et al.
Publicado: (2021)

ssDNA recombineering boosts in vivo evolution of nanobodies displayed on bacterial surfaces
por: Al-ramahi, Yamal, et al.
Publicado: (2021)

SARS-CoV-2 Fears Green: The Chlorophyll Catabolite Pheophorbide A Is a Potent Antiviral
por: Jimenez-Aleman, Guillermo H., et al.
Publicado: (2021)

Akt Kinase Intervenes in Flavivirus Replication by Interacting with Viral Protein NS5
por: Albentosa-González, Laura, et al.
Publicado: (2021)

Hepatitis B Virus and DNA Damage Response: Interactions and Consequences for the Infection
por: Gómez-Moreno, Andoni, et al.
Publicado: (2017)

West Nile Virus Replication Requires Fatty Acid Synthesis but Is Independent on Phosphatidylinositol-4-Phosphate Lipids
por: Martín-Acebes, Miguel A., et al.
Publicado: (2011)

Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus
por: Saiz, Juan-Carlos, et al.
Publicado: (2018)

Antiviral Properties of the Natural Polyphenols Delphinidin and Epigallocatechin Gallate against the Flaviviruses West Nile Virus, Zika Virus, and Dengue Virus
por: Vázquez-Calvo, Ángela, et al.
Publicado: (2017)

Current Progress of Avian Vaccines Against West Nile Virus
por: Jiménez de Oya, Nereida, et al.
Publicado: (2019)

Structure and inhibition of SARS-CoV-1 and SARS-CoV-2 main proteases by oral antiviral compound AG7404
por: Fàbrega-Ferrer, Montserrat, et al.
Publicado: (2022)

Pathogenicity and virulence of West Nile virus revisited eight decades after its first isolation
por: Saiz, Juan-Carlos, et al.
Publicado: (2021)

A Recombinant Subviral Particle-Based Vaccine Protects Magpie (Pica pica) Against West Nile Virus Infection
por: Jiménez de Oya, Nereida, et al.
Publicado: (2019)

Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target
por: García-Dorival, Isabel, et al.
Publicado: (2021)

A Single Amino Acid Substitution in the Core Protein of West Nile Virus Increases Resistance to Acidotropic Compounds
por: Martín-Acebes, Miguel A., et al.
Publicado: (2013)

Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
por: Ginex, Tiziana, et al.
Publicado: (2021)

Novel Nonnucleoside Inhibitors of Zika Virus Polymerase Identified through the Screening of an Open Library of Antikinetoplastid Compounds
por: Sáez-Álvarez, Yanira, et al.
Publicado: (2021)

Development of anti-membrane type 1-matrix metalloproteinase nanobodies as immunoPET probes for triple negative breast cancer imaging
por: Mulero, Francisca, et al.
Publicado: (2022)

Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara
por: Jiménez de Oya, Nereida, et al.
Publicado: (2022)

Previous Usutu Virus Exposure Partially Protects Magpies (Pica pica) against West Nile Virus Disease But Does Not Prevent Horizontal Transmission
por: Escribano-Romero, Estela, et al.
Publicado: (2021)

Response: Commentary: Zika Virus: the Latest Newcomer
por: Saiz, Juan-Carlos, et al.
Publicado: (2016)

Zika virus infection confers protection against West Nile virus challenge in mice
por: Vázquez-Calvo, Ángela, et al.
Publicado: (2017)

Widespread distribution of hepatitis E virus in Spanish pig herds
por: Jiménez de Oya, Nereida, et al.
Publicado: (2011)

Escherichia coli surface display for the selection of nanobodies
por: Salema, Valencio, et al.
Publicado: (2017)

A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants
por: Modhiran, Naphak, et al.
Publicado: (2023)

Nanobodies against SARS-CoV-2 reduced virus load in the brain of challenged mice and neutralized Wuhan, Delta and Omicron Variants
por: Pavan, María Florencia, et al.
Publicado: (2023)

A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice
por: Pérez, Patricia, et al.
Publicado: (2018)

Effect of Clinically Used Microtubule Targeting Drugs on Viral Infection and Transport Function
por: Oliva, María Ángela, et al.
Publicado: (2022)

Selecting Nanobodies Specific for the Epidermal Growth Factor from a Synthetic Nanobody Library
por: Serrano-Rivero, Yunier, et al.
Publicado: (2023)

Pharmacological Elevation of Cellular Dihydrosphingomyelin Provides a Novel Antiviral Strategy against West Nile Virus Infection
por: Jiménez de Oya, Nereida, et al.
Publicado: (2023)

The Scientific Response to Zika Virus
por: Martín-Acebes, Miguel A., et al.
Publicado: (2019)

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern
por: Wagner, Teresa R, et al.
Publicado: (2021)

High susceptibility of magpie (Pica pica) to experimental infection with lineage 1 and 2 West Nile virus
por: Jiménez de Oya, Nereida, et al.
Publicado: (2018)

The Host Factor Erlin-1 is Required for Efficient Hepatitis C Virus Infection
por: Whitten-Bauer, Christina, et al.
Publicado: (2019)

Recombinant expression of nanobodies and nanobody-derived immunoreagents
por: de Marco, Ario
Publicado: (2020)

Two pan-SARS-CoV-2 nanobodies and their multivalent derivatives effectively prevent Omicron infections in mice
por: Liu, Honghui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ui5fcfas44v4ghaerhotvmio2r